Pharmacological and Clinical Studies of Medicinal Plants That Inhibit Dipeptidyl Peptidase-IV
Drug Design, Development and Therapy · 2023
DOI: 10.2147/dddt.s426870 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2023. Verfasst von Rohani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Master Program in Pharmacy, Faculty of Pharmacy, Padjadjaran University, Sumedang, Indonesia. Hauptthemen laut MEDLINE: Plants, Medicinal, Diabetes Mellitus, Type 2, Dipeptidyl-Peptidase IV Inhibitors. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Master Program in Pharmacy, Faculty of Pharmacy, Padjadjaran University, Sumedang, Indonesia.
- Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Padjadjaran University, Sumedang, Indonesia.
- Department of Oral Medicine, Faculty of Dentistry, Padjadjaran University, Sumedang, Indonesia.
ORCID-Profile: Jutti Levita
Zitieren
APA
Rohani, Febrina, E., Wahyuni, I. S., & Levita, J. (2023). Pharmacological and Clinical Studies of Medicinal Plants That Inhibit Dipeptidyl Peptidase-IV. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s426870
Vancouver
Rohani, Febrina E, Wahyuni IS, Levita J. Pharmacological and Clinical Studies of Medicinal Plants That Inhibit Dipeptidyl Peptidase-IV. Drug Design, Development and Therapy. 2023. doi:10.2147/dddt.s426870
BibTeX
@article{Rohani2023,
author = {Rohani and Febrina, Ellin and Wahyuni, Indah Suasani and Levita, Jutti},
title = {Pharmacological and Clinical Studies of Medicinal Plants That Inhibit Dipeptidyl Peptidase-IV},
journal = {Drug Design, Development and Therapy},
year = {2023},
doi = {10.2147/dddt.s426870}
}
EUVIMED